Brief: Lifecore Biomedical Announces Cooperation Agreement With 22NW
July 1 (Reuters) - Anebulo Pharmaceuticals Inc ANEB.O :
* LIFECORE BIOMEDICAL ANNOUNCES COOPERATION AGREEMENT WITH
22NW
* LIFECORE BIOMEDICAL INC - TO ADD FOUR DIRECTORS TO BOARD
* LIFECORE BIOMEDICAL INC - 22NW SIGNS STANDSTILL AND
SUPPORT
AGREEMENT
* LIFECORE BIOMEDICAL: 22NW WILL WITHDRAW NOTICE OF
NOMINATIONS OF
DIRECTOR CANDIDATES AT 2023 ANNUAL MEETING
Source text for Eikon: ID:nGNX7k8TJf
Further company coverage: ANEB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise